Exceptional Response to Durvalumab and Tremelimumab in Pancreatic Acinar Cell Carcinoma With Ultramutated Phenotype Associated With a DNA Polymerase-ε Mutation

JCO Precision Oncology 2026

View at publisher
Authors: Benjamin Koh, Subotheni Thavaneswaran, Frank Lin, John P. Grady, Meghana Maddula, Koroush Shahsavar Haghighi, Maya Kansara, Min Li Huang, Mandy L. Ballinger, Robert John Simes, David M. Thomas, David Goldstein
DOI: 10.1200/po-25-01003
Cited by: 0
References: 18

Fields of Study & Subjects

Pancreatic and Hepatic Oncology Research Cancer Immunotherapy and Biomarkers Cancer Genomics and Diagnostics

Publication details

Journal / source
JCO Precision Oncology
Volume
10
Issue
2
Pages
e2501003–e2501003
Publication date
1 February 2026
Language
EN